Prognostic Value of BCL-2 Expression in Patients With Non-Small-Cell Lung Cancer: A Meta-Analysis and Systemic Review

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s89275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prognostic Value of Lymph Node Ratio in Patients With Pathological N1 Non-Small Cell Lung Cancer: A Systematic Review With Meta-Analysis

Translational Lung Cancer Research
Oncology
2016English

Clinicopathological and Prognostic Significance of Oct-4 Expression in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Prognostic Significance of Immune Cells in Non-Small Cell Lung Cancer: Meta-Analysis

Oncotarget
Oncology
2018English

Prognostic Value of microRNAs in Lung Cancer: A Systematic Review and Meta‑analysis

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Prognostic Value of Plasma Fibrinogen in Lung Cancer Patients: A Meta-Analysis

Journal of Cancer
Oncology
2018English

Predictive and Prognostic Value of 18f-Fluorodeoxyglucose Uptake Combined With Thymidylate Synthase Expression in Patients With Advanced Non-Small Cell Lung Cancer

Scientific Reports
Multidisciplinary
2019English

Prognostic Significance of Pigment Epithelium-Derived Factor Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy